(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.32%) $79.20
(-0.44%) $2.03
(0.17%) $2 313.60
(0.56%) $26.98
(0.52%) $967.60
(-0.08%) $0.932
(-0.16%) $10.97
(-0.14%) $0.797
(1.49%) $92.49
Live Chart Being Loaded With Signals
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders...
Stats | |
---|---|
Today's Volume | 30 250.00 |
Average Volume | 206 154 |
Market Cap | 160.83M |
EPS | €0 ( 2024-04-03 ) |
Next earnings date | ( €-0.120 ) 2024-05-21 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -5.24 |
ATR14 | €0.0110 (0.56%) |
Volume Correlation
ProQR Therapeutics NV Correlation
10 Most Positive Correlations | |
---|---|
ECHO | 0.961 |
SIOX | 0.958 |
MLVF | 0.954 |
IIN | 0.95 |
CDZI | 0.949 |
EXAS | 0.942 |
BTWN | 0.94 |
EXFO | 0.934 |
GDNR | 0.933 |
BKCH | 0.932 |
10 Most Negative Correlations | |
---|---|
SNPX | -0.971 |
UTME | -0.963 |
ISPO | -0.956 |
PDBC | -0.95 |
LARK | -0.944 |
KTTA | -0.943 |
RIVN | -0.937 |
OP | -0.936 |
HMNF | -0.934 |
PIII | -0.934 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ProQR Therapeutics NV Correlation - Currency/Commodity
ProQR Therapeutics NV Financials
Annual | 2023 |
Revenue: | €6.38M |
Gross Profit: | €6.38M (100.00 %) |
EPS: | €-0.340 |
FY | 2023 |
Revenue: | €6.38M |
Gross Profit: | €6.38M (100.00 %) |
EPS: | €-0.340 |
FY | 2022 |
Revenue: | €4.04M |
Gross Profit: | €1.56M (38.68 %) |
EPS: | €-0.910 |
FY | 2021 |
Revenue: | €1.35M |
Gross Profit: | €0.00 (0.00 %) |
EPS: | €-1.231 |
Financial Reports:
No articles found.
ProQR Therapeutics NV
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators